 STANS, SWITZERLAND ACCESSWIRE September 30, 2021 NLS Pharmaceutics Ltd. Nasdaq:NLSP, NLSPW NLS or the Company, a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that its Chief Executive Officer and Co-Founder Alex Zwyer is scheduled to present a corporate overview and meet with investors at The Micro Cap Rodeo Fall Harvest Conference to be held virtually October 5-8, 2021. 